NRIX EBITDA Margin

Nurix Therapeutics Inc · EBITDA Margin

NRIX logo

NRIX EBITDA Margin

Latest reported45.96%
NRIX EBITDA Margin (-18.03% → 45.96%)
High-resolution chart · PNG

NRIX ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Nurix Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-291.5468%
-324.2424%
-169.2416%
-438.9469%
-373.0454%
-352.4299%
-63.8984%
-18.0272%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.